Drug Discovery & Pharmaceuticals

RSS

IRB Barcelona and Amazon join forces to develop computational tool in the fight against COVID-19

There are currently more than 10,000 scientific articles related to coronavirus infections. In fact, in recent weeks, research to combat COVID-19 has accelerated, and more than 4,000 new academic papers have been published on potential vaccines, therapies, and treatments.

3 Apr 2020

Cobra Biologics and Karolinska Institutet join forces to develop DNA vaccine against COVID-19

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet, one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic.

31 Mar 2020

DSI alumni use computational design to quickly discover treatments for COVID-19

Two graduates of the Data Science Institute at Columbia University are using computational design to quickly discover treatments for the coronavirus.

21 Mar 2020

Researchers decode 3D architecture of SARS-CoV-2 main protease

Teams around the world are working hard to develop active substances against SARS-CoV-2. The structural analysis of functional proteins of the virus is very helpful for this goal. The function of a protein is closely related to its 3D architecture.

21 Mar 2020

CARB-X awards $2.86M to develop novel oral antibiotic to treat drug-resistant gonorrhea

Up to $2.86M has been awarded to a research team including Penn State scientists to develop a new oral antibiotic to treat multidrug-resistant gonorrhea, a sexually transmitted disease caused by bacteria that have developed resistance to all but one existing antibiotic.

20 Mar 2020

Scientists develop single-step method to produce water-soluble fullerene compounds for medicine

Scientists from the Skoltech Center for Energy Science and Technology and the Institute for Problems of Chemical Physics of Russian Academy of Sciences in collaboration with researchers from the Catholic University of Leuven developed a single-step method to obtain water-soluble fullerene compounds with remarkable biological properties, such as the ability to effectively suppress the human immunodeficiency virus

17 Mar 2020

Beijing Tide Pharmaceutical and Insilico Medicine announce cancer drug discovery collaboration

Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited, and Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines, announced today that they are entering a collaboration, applying artificial intelligence technology to drug discovery, to jointly accelerate the process for multiple types of cancer treatment.

16 Mar 2020

Single-drug therapy can attack several cellular targets using different modes of action

Clinicians combat the drug resistances of some cancer types by using a combination of different drugs. To make this approach more effective, chemists have designed a chemical conjugate that can simultaneously attack several cellular targets using different modes of action.

13 Mar 2020

'Virtual screening' identifies active substances with potential to combat coronavirus

The University of Basel is part of the global search for a drug to fight the rampant coronavirus. Researchers in the Computational Pharmacy group have so far virtually tested almost 700 million substances, targeting a specific site on the virus - with the aim of inhibiting its multiplication.

11 Mar 2020

Study uncovers novel relationships between SLCs and cytotoxic drugs in human cells

Solute carriers represent the largest family of transmembrane transporters in the human genome, with over 400 members arranged into 65 families.

9 Mar 2020

New route for total synthesis of tetrodotoxin

In Japan, puffer fish is considered a delicacy, but the tickle to the taste buds comes with a tickle to the nerves: fugu contains tetrodotoxin, a strong nerve toxin.

6 Mar 2020

SFU researchers help discover potential new drug to kill superbugs

Researchers in Simon Fraser University's Brinkman Laboratory are collaborating with U.S. researchers to test a new drug that can kill a wide range of superbugs - including some bacteria now resistant to all common antibiotics.

3 Mar 2020

New tool shows potential to predict developmental toxicity in humans with high accuracy

Recently published results from an evaluation of 1,065 chemical and drug substances using the devTOX quickPredict (devTOXqP) screening platform developed by Stemina Biomarker Discovery, Inc. demonstrated the platform's ability to predict developmental toxicity in humans with high accuracy using a cell-based test.

3 Mar 2020

WFIRM scientists develop miniature organ model to test drug toxicity

Scientists at the Wake Forest Institute for Regenerative Medicinehave developed the world's most sophisticated laboratory model of the human body, creating a system of miniaturized organs that can be used to detect harmful and adverse effects of drugs before they are prescribed to patients.

2 Mar 2020

Drug Discovery & Pharmaceuticals

IRB Barcelona and Amazon join forces to develop computational tool in the fight against COVID-19

Cobra Biologics and Karolinska Institutet join forces to develop DNA vaccine against COVID-19

DSI alumni use computational design to quickly discover treatments for COVID-19

Researchers decode 3D architecture of SARS-CoV-2 main protease

CARB-X awards $2.86M to develop novel oral antibiotic to treat drug-resistant gonorrhea

Scientists develop single-step method to produce water-soluble fullerene compounds for medicine

Beijing Tide Pharmaceutical and Insilico Medicine announce cancer drug discovery collaboration

Single-drug therapy can attack several cellular targets using different modes of action

'Virtual screening' identifies active substances with potential to combat coronavirus

Study uncovers novel relationships between SLCs and cytotoxic drugs in human cells

New route for total synthesis of tetrodotoxin

SFU researchers help discover potential new drug to kill superbugs

New tool shows potential to predict developmental toxicity in humans with high accuracy

WFIRM scientists develop miniature organ model to test drug toxicity

Researchers develop multi-organ-on-a-chip for drug toxicity screening

Boehringer Ingelheim and Trutino enter into research collaboration to advance cytokine therapies

McMaster researchers identify antibacterial compound made by cannabis plants

CQDM and GlycoNet collaborate to support innovative glycomics research in Canada

Essential oil components could meet the criteria set for drug candidates

Catalytic nanoreactors could simplify the manufacturing process of fine chemicals

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest Life Science News